Exelixis
EXEL
#1741
Rank
โ‚ฌ10.15 B
Marketcap
37,88ย โ‚ฌ
Share price
0.02%
Change (1 day)
19.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2025 (TTM): โ‚ฌ0.81 Billion

According to Exelixis's latest financial reports the company's current earnings are โ‚ฌ2.32 Billion. , an increase over its 2024 earnings that were of โ‚ฌ0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.81 B38.08%
2024 โ‚ฌ0.58 B164.69%
2023 โ‚ฌ0.22 B9.89%
2022 โ‚ฌ0.20 B-20.33%
2021 โ‚ฌ0.25 B124.82%
2020 โ‚ฌ0.11 B-67.14%
2019 โ‚ฌ0.34 B-11.94%
2018 โ‚ฌ0.38 B185.09%
2017 โ‚ฌ0.13 B-325.82%
2016 -โ‚ฌ60.47 Million-58.12%
2015 -โ‚ฌ0.15 Billion-37.61%
2014 -โ‚ฌ0.24 Billion9.75%
2013 -โ‚ฌ0.22 Billion65.96%
2012 -โ‚ฌ0.13 Billion-291.63%
2011 โ‚ฌ66.28 M-195.59%
2010 -โ‚ฌ69.35 Million-42.17%
2009 -โ‚ฌ0.12 Billion-18.98%
2008 -โ‚ฌ0.15 Billion-6.99%
2007 -โ‚ฌ0.16 Billion46.3%
2006 -โ‚ฌ0.11 Billion33.25%
2005 -โ‚ฌ81.64 Million-30.92%
2004 -โ‚ฌ0.12 Billion44.29%
2003 -โ‚ฌ81.9 Million12.86%
2002 -โ‚ฌ72.57 Million22.79%
2001 -โ‚ฌ59.1 Million60.14%
2000 -โ‚ฌ36.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.88 B 3,464.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ8.77 B 982.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.72 B 853.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.62 B 718.02%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ19.30 B 2,282.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.03 B 891.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ8.52 B 951.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-โ‚ฌ28.04 Million-103.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚ฌ25.01 Million-103.09%๐Ÿ‡บ๐Ÿ‡ธ USA